EcoDrugPlus

Ensembl ID : ENSDLAG00005022347
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSDLAG00005022382
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSDLAG00005022462
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSDLAG00005022516
Gene Symbol: -
Cross references: -
489 Possible Orthologues:

Ensembl ID : ENSDLAG00005000030
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSDLAG00005000074
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSDLAG00005001770
Gene Symbol: -
1 Cross references
200 Possible Orthologues:

Ensembl ID : ENSDLAG00005003470
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSDLAG00005003495
Gene Symbol: -
Cross references: -
332 Possible Orthologues:

Ensembl ID : ENSDLAG00005003608
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSDLAG00005003623
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSDLAG00005003646
Gene Symbol: -
Cross references: -
364 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).